Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 2: Comparison of the parametric values of the progression and nonprogression groups^{^a}
Parameters Progression (n = 71) Nonprogression (n = 15) P Value^{^b}
Mean tumor volume (mL) 119.84 ± 85.65 161.81 ± 102.59 .10
EF 95th PV (%) 11.053 ± 7.651 15.790 ± 8.693 .04
EF mean (%) 2.473 ± 1.552 3.140 ± 1.463 .13
K^trans 95th PV (min^–1) 0.140 ± 0.118 0.177 ± 0.132 .28
K^trans mean (min^–1) 0.022 ± 0.024 0.0260 ± 0.021 .59
Ve 95th PV 51.604 ± 71.965 44.480 ± 29.773 .71
Ve mean 7.750 ± 16.050 6.209 ± 4.917 .71
Vp 95th PV 5.334 ± 5.488 6.594 ± 4.807 .41
Vp mean 1.264 ± 1.352 1.384 ± 0.100 .75
Note:—PV indicates percentile value.
↵a Patients with a follow-up period of >24 months without progression (n = 15) or PFS of ≤24 months (n = 71) were analyzed.
↵b Calculated with an unpaired Student t test.

Parameters	Progression (n = 71)	Nonprogression (n = 15)	P Value^{^b}
Mean tumor volume (mL)	119.84 ± 85.65	161.81 ± 102.59	.10
EF 95th PV (%)	11.053 ± 7.651	15.790 ± 8.693	.04
EF mean (%)	2.473 ± 1.552	3.140 ± 1.463	.13
K^trans 95th PV (min^–1)	0.140 ± 0.118	0.177 ± 0.132	.28
K^trans mean (min^–1)	0.022 ± 0.024	0.0260 ± 0.021	.59
Ve 95th PV	51.604 ± 71.965	44.480 ± 29.773	.71
Ve mean	7.750 ± 16.050	6.209 ± 4.917	.71
Vp 95th PV	5.334 ± 5.488	6.594 ± 4.807	.41
Vp mean	1.264 ± 1.352	1.384 ± 0.100	.75